151 related articles for article (PubMed ID: 31927520)
1. Gender-based differences in the clustering of metabolic syndrome factors in children and adolescents.
Calcaterra V; Larizza D; De Silvestri A; Albertini R; Vinci F; Regalbuto C; Dobbiani G; Montalbano C; Pelizzo G; Cena H
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):279-288. PubMed ID: 31927520
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity.
Calcaterra V; Klersy C; Muratori T; Telli S; Caramagna C; Scaglia F; Cisternino M; Larizza D
Clin Endocrinol (Oxf); 2008 Jun; 68(6):868-72. PubMed ID: 17980007
[TBL] [Abstract][Full Text] [Related]
3. TriGlycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the chinese obese children: a cross section study.
Liang J; Fu J; Jiang Y; Dong G; Wang X; Wu W
BMC Pediatr; 2015 Sep; 15():138. PubMed ID: 26416207
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents.
Rizzo AC; Goldberg TB; Silva CC; Kurokawa CS; Nunes HR; Corrente JE
Nutr J; 2013 Jan; 12():19. PubMed ID: 23363783
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-21 and Visfatin as potential predictors for metabolic risk factors in obese children.
El-Masry SA; Farid MN; Hassan NE; Soliman MA; Mekkawy LH; Elashry GI; Abd El-Fattah SN
Sci Rep; 2024 Jan; 14(1):1190. PubMed ID: 38216702
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity.
Caceres M; Teran CG; Rodriguez S; Medina M
BMC Pediatr; 2008 Aug; 8():31. PubMed ID: 18700035
[TBL] [Abstract][Full Text] [Related]
8. High cardiometabolic risk in healthy Chilean adolescents: associations with anthropometric, biological and lifestyle factors.
Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
Public Health Nutr; 2016 Feb; 19(3):486-93. PubMed ID: 25990645
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
Shalitin S; Abrahami M; Lilos P; Phillip M
Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of metabolic syndrome and cardiovascular risk factors in a group of obese Saudi children and adolescents: a hospital-based study.
Taha D; Ahmed O; bin Sadiq B
Ann Saudi Med; 2009; 29(5):357-60. PubMed ID: 19700892
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance in obese children and adolescents.
Romualdo MC; Nóbrega FJ; Escrivão MA
J Pediatr (Rio J); 2014; 90(6):600-7. PubMed ID: 25019650
[TBL] [Abstract][Full Text] [Related]
12. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
[TBL] [Abstract][Full Text] [Related]
13. High HOMA-IR, adjusted for puberty, relates to the metabolic syndrome in overweight and obese Chilean youths.
Burrows RA; Leiva LB; Weisstaub G; Lera LM; Albala CB; Blanco E; Gahagan S
Pediatr Diabetes; 2011 May; 12(3 Pt 2):212-8. PubMed ID: 21426454
[TBL] [Abstract][Full Text] [Related]
14. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach.
Reinehr T; de Sousa G; Toschke AM; Andler W
Arch Dis Child; 2007 Dec; 92(12):1067-72. PubMed ID: 17301109
[TBL] [Abstract][Full Text] [Related]
15. Decreased high-density lipoprotein cholesterol and insulin resistance were the most common criteria in 12- to 19-year-old adolescents.
Budak N; Oztürk A; Mazicioglu M; Yazici C; Bayram F; Kurtoglu S
Eur J Nutr; 2010 Jun; 49(4):219-25. PubMed ID: 19876664
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of metabolic syndrome in children and adolescents who consult with obesity].
Eyzaguirre F; Silva R; Román R; Palacio A; Cosentino M; Vega V; García H
Rev Med Chil; 2011 Jun; 139(6):732-8. PubMed ID: 22051753
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty.
Tobisch B; Blatniczky L; Barkai L
Pediatr Obes; 2015 Feb; 10(1):37-44. PubMed ID: 24227418
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
[TBL] [Abstract][Full Text] [Related]
20. Predicting adult body mass index-specific metabolic risk from childhood.
Camhi SM; Katzmarzyk PT; Broyles S; Srinivasan SR; Chen W; Bouchard C; Berenson GS
Metab Syndr Relat Disord; 2010 Apr; 8(2):165-72. PubMed ID: 20156071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
